Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000899243-19-026927)

Filing Details

Accession Number:: 0000899243-19-026927
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2019-11-08 12:26:13
Reporting Period:: 2019-09-27

Accepted Time:: 2019-11-08 12:26:13
Original Submission Date:: 2019-10-02
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1415684	Musclepharm Corp	MSLP	()	4/A

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1008190	Mark Blundell	Co White Winston Select Asset Funds, Llc 265 Franklin St., Suite 1702 Boston MA 02110		No	No	Yes	No
1559652	P Robert Mahoney	Co White Winston Select Asset Funds, Llc 265 Franklin St., Suite 1702 Boston MA 02110		No	No	Yes	No
1647702	M. Todd Enright	Co White Winston Select Asset Funds, Llc 265 Franklin St., Suite 1702 Boston MA 02110		No	No	Yes	No
1647837	Donald Feagan	Co White Winston Select Asset Funds, Llc 265 Franklin St., Suite 1702 Boston MA 02110		No	No	Yes	No
1647840	White Winston Select Asset Funds, Llc	265 Franklin St., Suite 1702 Boston MA 02110		No	No	Yes	No
1738154	White Winston Select Asset Fund Series Fund Mp-18, Llc	265 Franklin St., Suite 1702 Boston MA 02115		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2019-09-30	626,826	$0.00	3,648,355	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

This Form 4 amends a Form 4 filed by the reporting person on October 2, 2019, which erroneously reported in Table I, Column 5 that the amount of securities beneficially owned following the reported transaction was 3,658,180, rather than 3,648,355.